Bentham Science Logo

Track Your Manuscript:


Clinical Cancer Drugs

Volume 7, 2 Issues, 2020
ISSN: 2212-6988 (Online)
ISSN: 2212-697X (Print)
This journal supports open access
Order Your Article Before PrintSubscribe to this Journal

In the current pandemic scenario, publication process of all articles related to Coronavirus will be expedited, for timely publication of much needed research

Articles Ahead of Print


A Phase I Study of OMN54 (Aneustat™) in Patients with Advanced Malignancies


Karen A Gelmon*, Christian Kollmannsberger, Stephen Chia, Anna V. Tinker, Teresa Mitchell, Stephen Lam, Teresa Joshi, David Kwok, John Ostrem, Simon Sutcliffe and Daniel J Renouf


DOI: 10.2174/1574893615999200601130946
View Abstract



Alsevirone-NF Reduces Serum Testosterone and Inhibits Prostate Cancer Xenograft Growth in Balb/c Nude Mice


Pokrovsky V.S.*, Zolottsev V.A., Latysheva A.S., Kudinov V.A., Anisimova N.Yu., Almanza R.L.M., Alekseeva O.Yu., Baskaev K.K., Smirnova G.B., Borisova Yu.A. and Ipatova O.M.


DOI: 10.2174/2212697X07999200511082225
View Abstract






Editor-in-Chief

Giulio Francia
The University of Texas
El Paso, TX
(USA)

Biography
View Full Editorial Board

Journal History

Clinical Cancer Drugs was introduced in 2014 with the assistance of Dr. Giulio Francia, who is the current Editor-in-Chief serving since 2014.

Advertisement

STATISTICS AND DATA PRESENTATIONCovid Resource Center

Related Journals

Related eBooks

eBooks Catalog